News

Elation Health and Dock Health Team to Optimize Clinical Operations and Improve Organizational Performance

Task management integration with Elation’s EHR reduces dropped balls, increases practice performance and improves patient experiences REDWOOD CITY, Calif.--(BUSINESS WIRE)--Elation…

2 years ago

 While Interoperability and Technology Have Made Significant Improvements in Healthcare, They Will Make an Even Bigger Impact on Care if Their Full Potential Can Be Reached, Physicians Say, According to a New athenahealth Survey

 Vast majority of physicians believe in the value of interoperability and technology in their daily practices Staffing shortages and high…

2 years ago

Wolters Kluwer Tax & Accounting cloud-based global expert solution named finalist in 2022 SIIA CODiE Awards

Cloud-based TeamMate+ Agile Audit named finalist in the Compliance Solution category NEW YORK--(BUSINESS WIRE)--#accounting--Today, Wolters Kluwer Tax & Accounting announced…

2 years ago

NEURO REHAB VR RELEASES THE FIRST STATE BOARD APPROVED VIRTUAL REALITY PHYSICAL THERAPIST CERTIFICATION PROGRAM

Neuro Rehab VR launched a program to certify physical therapists to treat patients with the XR Therapy virtual reality rehabilitation…

2 years ago

Watch the 2022 Anatomage Tournament Championship Today – Live on YouTube!

SANTA CLARA, Calif., June 9, 2022 /PRNewswire/ -- Anatomage Inc, a market leader in 3D medical virtualization technology, is thrilled to…

2 years ago

IIOT-OXYS, Inc. CEO and COO Renew Contracts Ensuring Long-Term Stability and Growth

CAMBRIDGE, MA / ACCESSWIRE / June 9, 2022 / IIOT-OXYS, Inc. (OTC PINK:ITOX) announced its CEO, Cliff Emmons, and COO,…

2 years ago

Jaguar Health and Filament Health Sign Letter of Intent to Develop Botanical Prescription Drugs for Specific Mental Health Indications

Drug Discovery Collaboration Will Leverage the Botanical Drug Development Expertise of Both CompaniesSAN FRANCISCO, CA / ACCESSWIRE / June 9,…

2 years ago

Aptevo Therapeutics Announces New Preliminary Remission Data on Four Additional Patients Enrolled in On-going APVO436 Dose Expansion Phase 1b Trial for the Treatment of Acute Myeloid Leukemia

Cohort 1 Combination Therapy Arm Shows 36% Remission Rate Among Response-evaluable Patients Treated to DateCohort 3 Monotherapy Patient Achieved Bone…

2 years ago

ORHub Retains Predica to Launch New Software Platform

"ORHub to launch new FutureORTM application in Q3 2022"IRVINE, CA / ACCESSWIRE / June 9, 2022 / ORHub, Inc. (OTC…

2 years ago

Sonnet BioTherapeutics Announces Positive Results from a Preclinical Combination Study of SON-1010 with anti-PD1 Checkpoint Inhibition

Tumor volume growth inhibition improvements observed with the combination of SON-1010 (IL12-FHAB) and a commercially available anti-PD1 antibodyCombination of SON-1010…

2 years ago